%0 Journal Article
%T Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial
%A Carine Wouters
%A Chris Wells
%A Diana Milojevic
%A Hans-Iko Huppertz
%A Inmaculada Calvo Penades
%A Joy C. Hsu
%A Kenneth Schikler
%A Margalit Rosenkranz
%A Navita L. Mallalieu
%A Rik Joos
%A Ruben Cuttica
%A Sunethra Wimalasundera
%A Tamas Constantin
%A Wendy Douglass
%A Yukiko Kimura
%J Archive of "Pediatric Rheumatology Online Journal".
%D 2019
%R 10.1186/s12969-019-0364-z
%K Biological therapy
%K Inflammation
%K Juvenile idiopathic arthritis
%K Pharmacokinetics
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704523/